GM1 to prevent nerve damage from breast cancer chemo
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 75 with breast cancer.
- You are scheduled to receive a chemotherapy drug called albumin-bound paclitaxel (also called nab-paclitaxel) as part of your treatment.
- You do not already have numbness, tingling, or pain in your hands or feet from nerve damage (peripheral neuropathy).
- You have not had any other cancer besides breast cancer.
- You can keep track of your symptoms and report them through simple questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial is testing a wearable device (gloves and boots) that applies gentle compression to your hands and feet during chemotherapy. It aims to prevent or reduce nerve damage (numbness, tingling, pain) that some chemotherapy drugs can cause.
This Phase 3 trial tests whether Stibium metallicum (a study supplement/medication) can prevent nerve damage in the hands and feet caused by paclitaxel chemotherapy. If you’re about to start a specific paclitaxel schedule for early breast cancer, this may help reduce the risk of painful numbness or tingling.
This trial tests if taking mecobalamin (a form of vitamin B12) can prevent or reduce nerve pain and numbness caused by taxane chemotherapy. It may help people getting chemo for several types of cancer.
This trial tests whether a gel called TAR-0520 can prevent nerve damage (peripheral neuropathy) caused by common breast cancer drugs like paclitaxel or docetaxel. You'll apply the gel to your skin, and the study will see if it helps reduce numbness, tingling, or pain in your hands and feet.
This trial tests a new drug called JMKX000189 to see if it can safely reduce nerve pain and tingling caused by cancer chemotherapy. If you've completed cancer treatment and are struggling with these symptoms, this study may help.
Hear when a new Chemotherapy-induced Peripheral Neuropathy (CIPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.